Your browser doesn't support javascript.
loading
Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma.
Li, Mengwei; Liu, Guangxiang; Jin, Xinrong; Guo, Hongqian; Setrerrahmane, Sarra; Xu, Xindi; Li, Tiantian; Lin, Yunfei; Xu, Hanmei.
Affiliation
  • Li M; The Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing, 210009, China.
  • Liu G; State Key Laboratory of Natural Medicines, Ministry of Education, China Pharmaceutical University, Nanjing, 210009, China.
  • Jin X; Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, Nanjing, 210008, Jiangsu, China.
  • Guo H; The Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing, 210009, China.
  • Setrerrahmane S; Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University, Nanjing, 210008, Jiangsu, China.
  • Xu X; NANJING ANJI BIOTECHNOLOGY CO. LTD, Nanjing, 210033, China.
  • Li T; The Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing, 210009, China.
  • Lin Y; The Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing, 210009, China.
  • Xu H; The Engineering Research Center of Synthetic Peptide Drug Discovery and Evaluation of Jiangsu Province, China Pharmaceutical University, Nanjing, 210009, China.
Mol Cancer ; 21(1): 181, 2022 09 19.
Article in En | MEDLINE | ID: mdl-36117171

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / RNA, Long Noncoding / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / RNA, Long Noncoding / Kidney Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Country of publication: